GlassScriptPhysician profile
Ray Blackwell
NPI 1033200084
$4,056.76
in general payments reported to CMS, 2019-2025
11 companies · $641 in 2025
The $641 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $488 · 2021: $80.70 · 2022: $127 · 2023: $2,356 · 2024: $364 · 2025: $641.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,899 · Food and Beverage: $1,461.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,899.38 |
| Food and Beverage | $1,461.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Artivion, INC. | $2,381.44 | 2019-2023 | Cardiac Non-Synergraft |
| Abiomed | $512.91 | 2023-2025 | Impella |
| Abbott Laboratories | $487.56 | 2022-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Triclip |
| Edwards Lifesciences Corporation | $344.25 | 2019-2025 | Evoque |
| Medtronic Vascular, INC. | $100.00 | 2019 | |
| Getinge USA Sales, LLC | $84.19 | 2021-2024 | Heartstring III Proximal Seal, Cardiohelp |
| Becton, Dickinson and Company | $39.54 | 2019 | |
| Ethicon US, LLC | $38.14 | 2024 | Stratafix, Evarrest, Prolene |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $28.69 | 2025 | |
| Baxter Healthcare | $26.36 | 2025 | Preveleak |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $13.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ray Blackwell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.